vTv Therapeutics Shares Initiated With Buy Rating, $13 Target

By: via Benzinga
HC Wainwright has started coverage of vTv Therapeutics Inc (NASDAQ: VTVT) with a Buy rating and $13 price target on the potential ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.